Header Logo

Connection

Matthew Meriggioli to Follow-Up Studies

Back to Details
This is a "connection" page, showing publications Matthew Meriggioli has written about Follow-Up Studies.
Matthew Meriggioli
Connection Strength
0.032
Follow-Up Studies
  1. Five-Year Extension Results of the Phase 1 START Trial of Onasemnogene Abeparvovec in Spinal Muscular Atrophy. JAMA Neurol. 2021 07 01; 78(7):834-841.
    View in: PubMed
    Score: 0.032
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.